Amdocs Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DOX research report →
Range $71 – $92
Price Chart
About the company
Amdocs Limited is a global provider of software solutions and associated services, operating through its various subsidiaries worldwide. The company is actively involved in the full lifecycle of its cloud-based portfolio, from designing and developing to operating, implementing, supporting, and marketing these open and modular offerings. Its diverse product lineup includes CES21, a leading customer experience suite built on 5G and cloud-native microservices architecture, which empowers service providers to develop, deliver, and monetize advanced services.
- CEO
- Shimie Hortig
- IPO
- 1998
- Employees
- 26,969
- HQ
- Saint Louis, MO, US
AI snapshot
Six angles, distilled from the data.
The stock remains in a longer-term downtrend, trading well below its 200-day average after a sharp reset from the 52-week high. That leaves it in a damaged but potentially stabilizing regime, with the recent action still far closer to the low end of the yearly range than to prior highs.
Street sentiment is constructive but cautious: the consensus sits at Buy, yet the average target has been pulled down to $71 from earlier levels. Recent actions skew softer, with Oppenheimer cutting to Perform and Stifel/Barclays trimming targets, signaling less enthusiasm even as coverage remains positive.
Execution has been steady, with Amdocs beating EPS in all 8 of the last 8 quarters. Next-year EPS is modeled higher at 8.03 versus 4.68 TTM, so shareholders should watch whether revenue growth and margin discipline can support that step-up rather than just another small beat.
The pattern leans modestly positive on discretionary activity, with 4 buys against 2 sells. Most of the share movement is award-related and should be treated as routine compensation flow, while the real signal is the open-market buying from directors alongside one officer sale cluster.
Profitability is solid, with a 38.1% gross margin, 17.7% operating margin, and 10.6% net margin. Growth is still positive but not explosive: revenue rose 3.8% year over year, while earnings growth was 54%, and free cash flow remained strong at $783.3 million.
Amdocs sits in the steadier end of the software-infrastructure group, with recurring telecom spending and lower beta than many peers. The valuation is undemanding at 6.17x earnings, which leaves room for rerating if growth and sentiment stabilize.
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.43B
- P/E
- 8.83
- Fwd P/E
- 7.53
- PEG
- -1.12
- P/S
- 0.95
- P/B
- 1.30
- EV/EBITDA
- 6.10
- Div Yield
- 5.40%
- Gross Margin
- 37.66%
- Op Margin
- 17.55%
- Net Margin
- 10.61%
- ROE
- 14.89%
- ROIC
- 12.97%
Latest fiscal year · YoY change
- Revenue
- $4.70B+3.6%
- Gross Profit
- $1.71B+3.2%
- Op Income
- $843.28M
- Net Income
- $501.24M-11.2%
- EPS
- $4.70-7.5%
- OCF Growth
- -10.2%
- FCF Growth
- -12.9%
- 52W High
- $84.95
- 52W Low
- $39.96
- 50D MA
- $56.06
- 200D MA
- $60.12
- Beta
- 0.41
- RSI (14)
- 23
- Avg Volume
- 1.42M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Amdocs posted solid fiscal Q4 and full-year FY2026 results, but FY2027 guidance points to a sharp decline because of a major T-Mobile dispute while the company pivots hard into AOS and insurance.· November 3, 2026
- Q4 revenue was about $1.194 billion, up 3.8% year over year; non-GAAP EPS was $1.98 and non-GAAP operating margin was 21.6%.
- Full-year FY2026 revenue was $4.697 billion, up 3.6% as reported and 3% in constant currency; non-GAAP EPS rose 6% and free cash flow before restructuring payments was $729 million.
- FY2027 guidance calls for revenue down 14.3% to 17.9% as reported, or down 7% to 11% on a pro forma constant-currency basis; non-GAAP operating margin is seen at 19.2% to 19.8% and non-GAAP EPS down 26% to 30%.
- Management said the rest of the business should grow mid-single digits in FY2027 ex-T-Mobile, supported by AOS wins at AT&T, VEON, Globe, VodafoneThree and Liberty Latin America.
- Amdocs announced the $340 million cash acquisition of EIS to enter insurance and said it authorized a 3% increase in the quarterly dividend, subject to approval.
Q4 FY2026 revenue was approximately $1.194 billion, up 3.8% year over year as reported and 4% in constant currency. Q4 non-GAAP operating margin was 21.6%, unchanged sequentially, and non-GAAP diluted EPS was $1.98, $0.01 above the guidance midpoint. GAAP diluted EPS was $1.35, below the guidance range of $1.48 to $1.56, primarily due to a restructuring charge of roughly $0.22 per share tied to the company’s internal transformation. For FY2026, revenue was $4.697 billion, up 3.6% as reported and 3% in constant currency; non-GAAP operating margin was 21.6%, up 20 basis points; and non-GAAP diluted EPS grew 6%. Free cash flow before restructuring payments was $729 million, and reported free cash flow was $562 million after $167 million of restructuring payments. For FY2027, Amdocs expects revenue to decline 14.3% to 17.9% as reported; after adjusting for the media divestiture and nonstrategic exits, revenue is expected to decline 7% to 11% in pro forma constant currency. Non-GAAP operating margin is guided to 19.2% to 19.8%, free cash flow before restructuring payments to $440 million to $500 million, and non-GAAP diluted EPS to decline 26% to 30%. For Q1 FY2027, revenue is expected to be $955 million to $995 million. The board authorized a 3% increase in the quarterly cash dividend to $0.586 per share, subject to shareholder approval.
Shimie Hortig framed the quarter as a transition point: the company is reorganizing around what he called the “agentic revolution,” with AOS as the core platform. He emphasized that the AT&T deal is a flagship win and that recent large AOS contracts show traction across telco, while EIS gives Amdocs an entry into insurance as a new growth engine. His tone was confident about the long term, but he repeatedly stressed that FY2027 will be financially difficult because of an isolated but significant T-Mobile situation and the resulting conservative assumptions.
Tal Rozenfeld said the quarter was solid operationally, with Q4 revenue of $1.194 billion, non-GAAP operating margin of 21.6%, and non-GAAP EPS of $1.98. He highlighted healthy cash generation: $202 million of free cash flow before restructuring payments in Q4, $729 million for FY2026, and $562 million after $167 million of restructuring payments. On the balance sheet, he cited cash of about $197 million and borrowings of roughly $950 million, then noted post-quarter actions including $66 million of Vubiquity sale proceeds, $500 million of term loans, and the $340 million EIS acquisition. For FY2027, he pointed to margin pressure from T-Mobile but also said profitability should improve through the year, with Q4 expected at the higher end of the annual margin range; he also said the company expects to return the majority of free cash flow to shareholders and slow buybacks as investment priority rises.
Analysts focused heavily on T-Mobile, asking how much revenue it represented, whether the issue could spread to other large customers, and whether the recent hardware-resale exits were repeating prior portfolio cleanup actions. Management declined to quantify T-Mobile revenue but said the issue is isolated and that the rest of the business is expected to grow mid-single digits, citing strong AOS momentum and new wins. Questions about the EIS acquisition centered on strategic fit and integration risk; management said insurance is a deliberate new vertical, that a new unit will report directly to the CEO, and that the company is not pursuing a multi-vertical expansion beyond insurance. On AI, management argued it is a major opportunity rather than a threat, positioning AOS and Amdocs’ telecom expertise as a way to help customers move toward more autonomous operations.
The bull case from this call is that Amdocs is seeing real traction in its AOS strategy, including a major 8-year AT&T agreement and additional wins at VEON, Globe, VodafoneThree, and Liberty Latin America. Management also said the rest of the business should still grow mid-single digits in FY2027 ex-T-Mobile, while the insurance entry through EIS expands the addressable market and could create a second growth engine. Internal agentic transformation is already producing productivity gains, and management expects stronger growth and profitability in FY2028.
The clear bear case is that FY2027 guidance is materially weaker because of the T-Mobile situation, which management said could include termination of agreements and has already pressured revenue and profitability. Reported and adjusted revenue guidance both fall, margins are expected to contract by about 200 basis points at the midpoint, and non-GAAP EPS is guided down 26% to 30%. There is also execution risk around integrating EIS into a new vertical, and management did not provide detail on T-Mobile revenue exposure or the legal dispute.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 94.7%
- Shares Outstanding
- 107.57M
- Float Shares
- 101.87M
of shares held by institutions
465 13F filers
Buy/sell ratio 3.75. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for DOX, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Gilbert CisnerosHouse · CA31 | Sell | Nov 12, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Oct 15, 25 | Filing → |
| Val HoyleHouse · OR04 | Sell | Sep 23, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Sep 22, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Oct 1, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Sep 30, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Aug 26, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Aug 27, 25 | Filing → |
| Val HoyleHouse · OR04 | Buy | Apr 15, 25 | Filing → |
| Gilbert CisnerosHouse · CA31 | Sell | Jun 30, 25 | Filing → |
| Julie JohnsonHouse · TX32 | Sell | Feb 11, 25 | Filing → |
| Diana HarshbargerHouse · TN01 | Sell | Nov 15, 22 | Filing → |
| Diana HarshbargerHouse · TN01 | Sell | Nov 16, 22 | Filing → |
| Diana HarshbargerHouse · TN01 | Buy | Jul 22, 22 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Pzena Investment Management LLC | 14.45M | ▲ 469.58K |
| Fmr LLC | 6.12M | ▼ 3.91M |
| Dimensional Fund Advisors LP | 4.73M | ▲ 630.39K |
| Brandes Investment Partners, LP | 4.58M | ▼ 73.45K |
| Lsv Asset Management | 4.50M | ▼ 11.32K |
| Blackrock, Inc. | 4.38M | ▲ 1.02M |
| Beutel, Goodman & Co Ltd. | 4.31M | ▼ 301.09K |
| Federated Hermes, Inc. | 3.19M | ▲ 48.67K |
| Vanguard Group Inc | 3.06M | ▼ 9.24K |
| Vanguard Portfolio Management LLC | 2.75M | ▲ 13.97K |
| Aqr Capital Management LLC | 2.63M | ▲ 342.60K |
| Geode Capital Management, LLC | 2.04M | ▼ 94.60K |
Held by 411 ETFs
Biggest fund positions in DOX by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 3, 26 | Hortig Shimie | other | 18,614 |
| Nov 14, 26 | Hortig Shimie | sell | 5,642 |
| Nov 15, 26 | Hortig Shimie | sell | 7,255 |
| Nov 3, 26 | Raheja Rajat | other | 2,340 |
| Nov 14, 26 | Raheja Rajat | other | 780 |
| Nov 14, 26 | Raheja Rajat | other | 390 |
| Nov 14, 26 | Raheja Rajat | other | 780 |
| Nov 10, 26 | Raheja Rajat | other | 746 |
| Nov 15, 26 | Raheja Rajat | other | 701 |
| Nov 15, 26 | Raheja Rajat | other | 350 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our DOX coverage
Recent articles, reports, and earnings notes.
No research on DOX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DOX report →ROSEN, A LONGSTANDING FIRM, Encourages Amdocs Limited Investors to Inquire About Securities Class Action Investigation - DOX
newsfilecorp.com · Nov 20
DOX Investors: BFA Law Notifies Amdocs Investors with Losses of its Ongoing Securities Fraud Investigation
globenewswire.com · Nov 20
Edgestream Partners L.P. Makes New $4.08 Million Investment in Amdocs Limited $DOX
defenseworld.net · Nov 20
Amdocs Limited Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your DOX Investments
newsfilecorp.com · Nov 19
Amdocs Investor News: If You Have Suffered Losses in Amdocs Limited (NASDAQ: DOX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
globenewswire.com · Nov 19
HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Investigating Amdocs Limited (NASDAQ: DOX) Following Escalating T-Mobile Contract Dispute and Stock Collapse
prnewswire.com · Nov 19
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amdocs Limited - DOX
prnewswire.com · Nov 19
DOX Investigation: Amdocs is being Investigated for Securities Fraud Following T-Mobile Agreement Issues – Contact BFA Law if You Lost Money
globenewswire.com · Nov 18
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.
AI analysis · Last refreshed November 14, 2026 · Live quote · Not investment advice